FindTrial
Sign In

Lifestyle as a Prognostic Indicator in Drug Naive patients in Major Depressive Disorder

Lifestyle as a Prognostic Indicator in Drug Naive patients in Major Depressive Disorder - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097253
Enrollment
53
Registered
2025-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F332- Major depressive disorder, recurrent severe without psychotic features

Interventions

Intervention1: Nil: Nil

Sponsors

Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient aged 18-59 Diagnosed with measured Major Depressive Disorder as per ICD-10 criteria by qualified psychiatrist Willing & able to provide written informed consent Able to participate in follow - up evaluation

Exclusion criteria

Exclusion criteria: Patient currently diagnosed with any psychiatric disorder patient diagnosed with any endocrine disorder or any other neurological illness patient with severe depression

Design outcomes

Secondary

MeasureTime frame
NILTimepoint: NIL—

Primary

MeasureTime frame
to evaluate effect of lifestyle in drug naive major depressive disorderTimepoint: to evaluate effect of lifestyle in drug naive patient of major depressive disorder at baseline,4 weeks—

Countries

India

Contacts

Public ContactSaumya Verma

GSVM Medical College,Kanpur

drdollyrastogi@gmail.com8400331162

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026